en · de · es
field-notes.peptides4088.com › Info › Molecular Background And Naming — Research Overview

Molecular Background And Naming — Research Overview

By Editorial Desk · published 2026-06-01 · last reviewed 2026-07-13 · Info

This is a working overview of lyophilized powder, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-07-13 and is reviewed periodically as new material appears.

Molecular Background and Naming

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

Background and Naming Conventions

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.

Cjc-1295 at a glance

PropertyValueNotes
Molecular weight (no linker)~3.37 kDaCalculated from peptide sequence
Molecular weight (with linker)~3.65 kDaIncludes albumin-binding moiety
AppearanceWhite to off-white powderTypically lyophilized
SolubilitySoluble in waterAlso dissolves in aqueous buffers
Common synonymsModified GRF(1-29), DAC:GRFUsage varies by source

Receptor Action and Clearance

Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.

Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Related pages on this site

Compound Identity and Development History

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

Reference notes

=== Ootheca === Ootheca can be used as a distinguishing trait between the species of Eupolyphaga. E. sinensis ootheca are reddish brown in color with long arched serrations along one side, and compact ridges run longitudinal along the surface.

In April 1927, Chiang Kai-shek purged the communists in the Shanghai Massacre, causing the collapse of the First United Front and the split within the Nationalists between the Nanjing and Wuhan governments. Despite his past alliances of convenience with progressives, Liu Wenhui joined with every other major Sichuan warlord to issue a joint telegram, declaring the orders of the Wuhan government "invalid." Later that year, he made a secret pact with fellow Baoding officers Tian Songyao and Deng Xihou, wherein Liu would support Deng and Tian in an offensive to take control of Chongqing, and the two would support Liu in his campaign to take over Xikang from Liu Chengxun. The planned offensive against Chongqing did not happen.

=== Shape === Circulating inactivated platelets are biconvex discoid (lens-shaped) structures, 2–3 μm in greatest diameter. Activated platelets have cell membrane projections covering their surface. In a first approximation, the shape can be considered similar to oblate spheroids, with a semiaxis ratio of 2 to 8. This approximation can be used to model the hydrodynamic and optical properties of a population, as well as to restore the geometric parameters of individual measured platelets by flow cytometry. More accurate biophysical models of platelet surface morphology that model its shape from first principles make it possible to obtain a more realistic platelet geometry in a calm and activated state.

==== Thermoplastic adhesives ==== These represent the most widespread class of textile adhesives, favored for their low toxicity and ease of application. Products such as Mowilith® DMC2, Vinamul® 3252, Vinnapas® EP1 are used with fragmented silks and friable cellulosics like cotton. Beva® 371 is typically used with painted textiles due to its solubility in white spirits (mineral spirits), which don't damage the painted surface. Lascaux 360HV is favored for highly degraded materials because of its low activation temperature.

Sources: en.wikipedia.org

Reference notes

1920: South African botanist Louisa Bolus was elected a Fellow of the Royal Society of South Africa for her contributions to botany. Over the course of her lifetime, Bolus identified and named more than 1,700 new South African plant species - more species than any other botanist in South Africa. 1921: Edelmira Inés Mórtola, the first woman to become a geologist in Argentina, was awarded her PhD by the University of Buenos Aires, the first woman to received her doctorate there. The university named the Mórtola Mineralogy Museum in her honor. 1922: American anatomist, physician and histologist Katharine Bishop and Herbert McLean Evans co-discovered Vitamin E while studying the reproductive cycle of rats. 1923: Argentine physician María Teresa Ferrari earned the first diploma awarded to a woman by the Faculty of Medicine at the University of Paris for her studies of the urinary tract. 1924: Florence Bascom became the first woman elected to the Council of the Geological Society of America. 1925: Mexican-American botanist Ynes Mexia embarked on her first botanical expedition into Mexico, collecting over 1500 plant specimens. Over the course of the next thirteen years, Mexia collected more than 145,000 specimens from Mexico, Alaska, and multiple South American countries. She discovered 500 new species. 1925: American medical scientist Florence Sabin became the first woman elected to the National Academy of Sciences.

== Awards and honours == 2011 American Chemical Society Cincinnati Chemist of the Year 2015 American Microchemical Society Benedetti Pichler Award 2016 Power List of Top 50 Women Analytical Scientists 2016 Fellow of the Royal Society of Chemistry 2021 The Chromatography Forum of the Delaware Valley Stephen Dal Nogare Award

The thrifty gene hypothesis (also called the famine hypothesis) states that in some populations the body would be more efficient at retaining fat in times of plenty, thereby endowing greater resistance to starvation in times of food scarcity. This hypothesis, originally advanced in the context of glucose metabolism and insulin resistance, has been discredited by physical anthropologists, physiologists, and the original proponent of the idea himself with respect to that context, although according to its developer it remains "as viable as when [it was] first advanced" in other contexts. In 1995, Jeffrey Friedman, in his residency at the Rockefeller University, together with Rudolph Leibel, Douglas Coleman et al. discovered the protein leptin that the genetically obese mouse lacked. Leptin is produced in the white adipose tissue and signals to the hypothalamus. When leptin levels drop, the body interprets this as a loss of energy, and hunger increases. Mice lacking this protein eat until they are four times their normal size. Leptin, however, plays a different role in diet-induced obesity in rodents and humans. Because adipocytes produce leptin, leptin levels are elevated in the obese. However, hunger remains, and—when leptin levels drop due to weight loss—hunger increases. The drop of leptin is better viewed as a starvation signal than the rise of leptin as a satiety signal. However, elevated leptin in obesity is known as leptin resistance. The changes that occur in the hypothalamus to result in leptin resistance in obesity are currently the focus of obesity research.

In addition to the myoglobinuria, two other mechanisms contribute to kidney impairment: low blood pressure leads to constriction of the blood vessels and therefore a relative lack of blood flow to the kidney, and finally, uric acid may form crystals in the tubules of the kidneys, causing obstruction. Together, these processes lead to acute tubular necrosis, the destruction of the cells of the tubules. Glomerular filtration rate falls, and the kidney is unable to perform its normal excretory functions. This disrupts electrolyte regulation, leading to a further rise in potassium levels, and interferes with vitamin D processing, further worsening the low calcium levels.

Calcitonin receptor-like (CALCRL), also known as the calcitonin receptor-like receptor (CRLR), is a protein that in humans is encoded by the CALCRL gene. This protein is a component of 3 distinct receptors that are activated by hormones like calcitonin gene-related peptide and adrenomedullin.

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 a natural hormone?

No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.

Why do two versions share one name?

Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.

What is the relationship to GRF(1-29)?

The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.

Does this compound occur naturally in the body?

No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.

Network